59 related articles for article (PubMed ID: 6172801)
1. Approaches to prostatic 5 alpha-reductase inhibitors.
Batzold FH
Prog Clin Biol Res; 1981; 75B():269-82. PubMed ID: 6172801
[No Abstract] [Full Text] [Related]
2. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
3. Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.
Kadohama N; Wakisaka M; Kim U; Karr JP; Murphy GP; Sandberg AA
J Natl Cancer Inst; 1985 Feb; 74(2):475-86. PubMed ID: 3856054
[TBL] [Abstract][Full Text] [Related]
4. New biochemical methods to determine androgen sensitivity of prostatic cancer: the relative enzymatic index (REI).
Isaacs JT; Scott WW; Coffey DS
Prog Clin Biol Res; 1979; 33():133-44. PubMed ID: 294593
[No Abstract] [Full Text] [Related]
5. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
[TBL] [Abstract][Full Text] [Related]
6. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
[TBL] [Abstract][Full Text] [Related]
7. Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
Bruchovsky N; McLoughlin MG; Rennie PS; To MP
Prog Clin Biol Res; 1981; 75A():161-75. PubMed ID: 6175974
[No Abstract] [Full Text] [Related]
8. Rationale and practice of testing chemotherapeutic agents for prostate cancer.
Sandberg AA
Urology; 1981 Apr; 17(4 Suppl):34-44. PubMed ID: 7210392
[No Abstract] [Full Text] [Related]
9. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
10. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostatic 5alpha-reductase and 3alpha-hydroxysteroid dehydrogenase by two antiandrogens.
Dupuy GM; Roberts KD; Bleau G; Chapdelaine A
J Steroid Biochem; 1977 Nov; 8(11):1145-51. PubMed ID: 926781
[No Abstract] [Full Text] [Related]
12. [Expression of type I and type II 5alpha-reductase isoenzymes in prostate cancer tissues].
Ye L; Zhang Y; Fang Z
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1504-7. PubMed ID: 16200776
[TBL] [Abstract][Full Text] [Related]
13. Studies on a 5 alpha-reductase inhibitor and their therapeutic implications.
Petrow V; Lack L
Prog Clin Biol Res; 1981; 75B():283-97. PubMed ID: 7323098
[No Abstract] [Full Text] [Related]
14. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.
Ji Q; Chang L; VanDenBerg D; Stanczyk FZ; Stolz A
Prostate; 2003 Mar; 54(4):275-89. PubMed ID: 12539226
[TBL] [Abstract][Full Text] [Related]
15. [In vitro inhibitory effects of 16-methyl-substituted steroids on 5 alpha-reductase in rat and human prostates].
Faredin I; Tóth I; Wölfling J; Schneider GY; Meskó E
Acta Pharm Hung; 1994 Sep; 64(5):171-4. PubMed ID: 7817769
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH).
Rennie PS; Bruchovsky N; McLoughlin MG; Batzold FH; Dunstan-Adams EE
J Steroid Biochem; 1983 Jul; 19(1A):169-73. PubMed ID: 6193340
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
Lee C; Murphy GP; Chu TM
Cancer Res; 1980 Apr; 40(4):1245-8. PubMed ID: 7357554
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-reductase isozymes and androgen actions in the prostate.
Zhu YS; Imperato-McGinley JL
Ann N Y Acad Sci; 2009 Feb; 1155():43-56. PubMed ID: 19250191
[TBL] [Abstract][Full Text] [Related]
19. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
[TBL] [Abstract][Full Text] [Related]
20. 5alpha-reductase inhibitors.
Rittmaster RS
J Androl; 1997; 18(6):582-7. PubMed ID: 9432130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
